Medicine
ProAir RespiClick 90 mcg inhalation powder
ProAir RespiClick 90 mcg inhalation powder is a prescription medicine containing Albuterol for inhalation use, marketed by Teva Respiratory, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature (between 15°C and 25°C, 59°F and 77°F).
Key facts
- Active ingredient (INN)
- Albuterol
- Brand
- ProAir RespiClick
- Strength
- 90 mcg
- Dosage form
- Inhalation powder
- Route
- Inhalation
- Packs
- 1 inhaler
- Marketing authorisation holder
- Teva Respiratory
- Manufacturer
- Teva Respiratory
- Origin register
- US FDA, United States
- Storage
- Store at room temperature (between 15°C and 25°C, 59°F and 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- R03AC02 Albuterol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 April 2015
- Identifiers
- RxCUI 1649560, 1649961DailyMed set ID 9324e2eb-26fd-4f14-9f10-e5aa467306f4NDC 59310-580Application NDA205636
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 inhaler in 1 box / 200 powder, metered in 1 inhaler | 59310-580-20 | Teva Respiratory | 11 May 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 1 May 1981 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Albuterol
Clinical summary
Albuterol is a beta2-adrenergic agonist indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. MedsAcross supplies Albuterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AlbuterolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Albuterol Sulfate prescribing information (Sandoz) · U.S. National Library of Medicine, DailyMed
Need ProAir RespiClick 90 mcg inhalation powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.